Page last updated: 2024-10-26

dicyclomine and Prostatic Neoplasms

dicyclomine has been researched along with Prostatic Neoplasms in 1 studies

Dicyclomine: A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.
dicyclomine : The ester resulting from the formal condensation of 1-cyclohexylcyclohexanecarboxylic acid with 2-(diethylamino)ethanol. An anticholinergic, it is used as the hydrochloride to treat or prevent spasm in the muscles of the gastrointestinal tract, particularly that associated with irritable bowel syndrome.

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research Excerpts

ExcerptRelevanceReference
"The microarray database of prostate cancer shows a dominant expression of CHRM1 in prostate cancer compared with other cholinergic subtypes."1.46Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer. ( Abbas, F; Ahmad, HR; Effendi, V; Khan, NA; Mannan Baig, A; Rana, Z, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mannan Baig, A1
Khan, NA1
Effendi, V1
Rana, Z1
Ahmad, HR1
Abbas, F1

Other Studies

1 other study available for dicyclomine and Prostatic Neoplasms

ArticleYear
Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer.
    Anti-cancer drugs, 2017, Volume: 28, Issue:1

    Topics: Cell Line, Tumor; Cell Proliferation; Dicyclomine; Humans; Male; Pirenzepine; Prostatic Neoplasms; P

2017